Compare Becton Dickinson and Co (BDX) vs Stanley Black & Decker, Inc. (SWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Stanley Black & Decker, Inc. — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $41.51B), while Stanley Black & Decker, Inc. trades at $86.5 (market cap $13.58B). The key difference: Becton Dickinson and Co is far larger — about 3.1× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.8%). Which is the better fit depends on your goals.
| BDX | SWK | |
|---|---|---|
Market Cap | $41.51B | $13.58B |
Sector | Health | — |
52-Week High | $185.39 | $94.12 |
52-Week Low | $135.49 | $62.12 |
Enterprise Value | $57.97B | $19.75B |
Dividend Yield | 2.79% | 3.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Stanley Black & Decker (SWK) trades at $86.53, down 1.92% on the day, with a bearish technical signal but recent earnings beats. The company shows modest revenue of $15.13B in 2025 and a net income margin of 2.44%, though profitability metrics like ROE at 4.17% remain subdued. A dividend of $0.83 was recently declared, with cash flow from operations positive at $971.20M. Analyst consensus is mixed with 43% buy ratings but a price target below the current price.
SWK faces headwinds from weak Tools & Outdoor demand and high debt, though cost-saving efforts and aerospace growth offer upside. The stock's valuation at a P/E of 35.46 appears stretched relative to earnings growth, suggesting cautious optimism hinges on execution improvements and debt reduction. Risks include consumer sentiment and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Stanley Black & Decker, Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →
